secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001558370-23-006343
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio amends ATM equity program; up to $100M authorized, ~$8M remaining
-----------------------------------------------------------------------------

- Amendment No. 3 to At Market Issuance Sales Agreement dated April 14, 2023.
- Total ATM offering capacity remains $100M; ~$92M already sold, ~$8M available.
- Adds Instruction I.B.6 limitations based on non-affiliate market cap; removes Oppenheimer & Co. as agent.
- No securities sold under Instruction I.B.6 in prior 12 months; program continues under existing registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000155837023006343/0001558370-23-006343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000155837023006343/tmb-20230414x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-006343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer